ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,137Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 127

$1.19M Total Retail Price of All Prescriptions

Rank: 7 out of 127

414 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 414 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

3% of this provider’s 414 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 2,651 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$130 was the average price of a prescription from this provider, compared to $141 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
FLUOXETINE HCL 440 160 1 11
TRAZODONE HCL 380 83 2 1
SERTRALINE HCL 338 116 3 5
LOXAPINE 329 77 10 4 44
RISPERIDONE 279 69 5 2
GABAPENTIN 267 84 6 25
DIVALPROEX SODIUM ER 266 25 7 14
PAROXETINE HCL 263 100 8 26
OLANZAPINE 253 122 9 13
CYMBALTA 247 91 10 6
QUETIAPINE FUMARATE 241 85 11 7
SEROQUEL XR 215 79 12 19
ZIPRASIDONE HCL 194 11 13 21
ABILIFY 194 54 13 4
LEVOTHYROXINE SODIUM 189 60 15 40
CITALOPRAM HBR 188 75 16 3
DIVALPROEX SODIUM 185 63 17 23
ZOLPIDEM TARTRATE 161 47 18 9
MIRTAZAPINE 156 111 19 12
VENLAFAXINE HCL ER 151 67 20 15
TOPIRAMATE 146 13 21 28
AMPHETAMINE SALT COMBO 142 12 S2 22 37
BENZTROPINE MESYLATE 136 0 R 23 10
CARBAMAZEPINE 120 0 24 47
PROPRANOLOL HCL 113 21 25 39
BUSPIRONE HCL 107 19 26 20
HALOPERIDOL 96 29 27 29
METFORMIN HCL 91 0 28 69
LAMOTRIGINE 91 13 28 8
ZYPREXA 90 23 30 64
LATUDA 90 0 30 42
PRISTIQ ER 90 49 30 30
SEROQUEL 87 35 33 24
OXYCODONE HCL 86 0 S2 34 54
NAMENDA 83 36 35 34
HYDROCODONE-ACETAMINOPHEN 73 0 S3 36 36
INVEGA 70 11 37 33
EXELON 67 49 38 53
BUPROPION XL 64 25 39 16
CLOZAPINE 63 28 40 17
FUROSEMIDE 55 0 41 86
LISINOPRIL 52 0 42 71
DEXTROAMPHETAMINE-AMPHETAMINE 51 25 S2 43 93
GEODON 50 0 44 45
LACTULOSE 50 0 44 96
VENLAFAXINE HCL 50 31 44 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.